This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the use of the Galleri Test, a multi-cancer early detection test in development by GRAIL, and the results from the SYMPLIFY Study in symptomatic patients presented at ASCO.
Ticker(s): ILMNWho's the expert?
Institution: Hartford Healthcare Medical Group
- Medical onolcogist
- has used the Galleri Test once
- familiar with the results from the SYMPLIFY study of the Galleri test in the symptomatic patient population presented at ASCO "I’ve read summary of trial"
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
